Deutsche Bank
SER icon

Deutsche Bank’s Serina Therapeutics SER Stock Holding History

Deutsche Bank’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-31
Closed -$1K – 4463
2020
Q2 		$1K Sell
31
-168
-84% -$4.95K ﹤0.01% 4218
2020
Q1 		$6K Sell
199
-12
-6% -$564 ﹤0.01% 4125
2019
Q4 		$12K Buy
211
+41
+24% +$2.21K ﹤0.01% 4456
2019
Q3 		$10K Sell
170
-285
-63% -$27K ﹤0.01% 4511
2019
Q2 		$58K Buy
455
+141
+45% +$19.1K ﹤0.01% 4459
2019
Q1 		$44K Sell
314
-50
-14% -$7.31K ﹤0.01% 4594
2018
Q4 		$37K Buy
+364
New +$46.3K ﹤0.01% 4588

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
SWIG
Strategic Wealth Investment Group Louisville, Kentucky $788M AUM 14.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Deutsche Bank's SER Position: Q3 2020 in Review

Deutsche Bank sold out of Serina Therapeutics (SER) in Q3 2020, closing a stake of 31 shares — an estimated $1K sold.

Deutsche Bank first reported a position in SER in Q4 2018 and held it in 7 quarters. The position peaked at $58K in Q2 2019. 36 funds tracked by Wall St. Rank hold SER as of Q3 2020.

  • Deutsche Bank reported no remaining Serina Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Deutsche Bank sold 31 Serina Therapeutics shares in Q3 2020, an estimated $1K.
  • Deutsche Bank first reported a position in Serina Therapeutics in Q4 2018 and held it in 7 quarters.
  • Deutsche Bank's Serina Therapeutics position peaked at $58K in Q2 2019.
  • 36 funds tracked by Wall St. Rank held Serina Therapeutics as of Q3 2020.

Based on Deutsche Bank's 13F filing for Q3 2020, filed 12 Nov 2020.